Wechselwirkungen · Prevymis
PREVYMIS 20 mg granules in sachet PREVYMIS 120 mg granules in sachet · Abschnitt 4.5 · PDF-Seite 80
HOS-139955 · Präparat HOS-098408
When letermovir is co-administered with cyclosporine, refer also to the glyburide prescribing information for specific dosing recommendations. Antiepileptic medicinal products (see also general text) carbamazepine, Interaction not studied. Carbamazepine or phenobarbital may phenobarbital Expected: decrease plasma concentrations of ↓ letermovir letermovir. Co-administration of letermovir and (P-gp/UGT induction) carbamazepine or phenobarbital is not recommended. phenytoin Interaction not studied. Phenytoin may decrease plasma Expected: concentrations of letermovir. ↓ letermovir Letermovir may decrease the plasma (P-gp/UGT induction) concentrations of phenytoin.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): phenobarbital (HOS-085617) carbamazepine (HOS-085618) glyburide (HOS-109273) cyclosporine (HOS-084512) phenytoin (HOS-084531)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-12T02:00:00Z · SHA-256 db4998a6cb590006789107af9f09c4196d815ed441a57d076042c2223b8d34a9 · Passage 2a23bf6bd20c53d339b0f32a1cbfaddec72d99c00b577797f210cbf745f7ff04 · Zeichen 29558–30799 im Abschnitt